PMDA — authorised 23 December 2022
- Marketing authorisation holder: Leo Pharma K.K.
- Status: approved
🇯🇵 Adbry in Japan
PMDA authorised Adbry on 23 December 2022
Marketing authorisation
Adbry in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Adbry approved in Japan?
Yes. PMDA authorised it on 23 December 2022.
Who is the marketing authorisation holder for Adbry in Japan?
Leo Pharma K.K. holds the Japanese marketing authorisation.